News

Florida Atlantic University’s Human Powered Submarine (HPS) team recently was awarded first place for agility, as well as the Overall Runner-Up award, and had the fastest lap on the second day of racing at the First European International Submarine Race (eISR) at QinetiQ’s Ocean Basin testing facility in Haslar, Gosport, England.

The Employ Florida Banner Center for Life Sciences at Palm Beach State College has entered into a year-long agreement to offer industry-driven workshops at Scripps Florida, a division of the nonprofit Scripps Research Institute. The workshops are being presented onsite in Jupiter for Scripps Florida staff, students and faculty.

Students are picking up complimentary Vplenish vitamin boost packets right next to the sugar and other sweeteners when they buy a beverage. By tearing open the green packet and mixing the powder with a hot or cold beverage, or

FLORIDA’S BioPulse
First Edition
Spring/Summer 2012
A Snapshot of the Bioscience Industry   PDF LINK

Dr. Claudia Hillinger of the Max Planck Florida Institute (MPFI) in Jupiter, Fla. was presented with the German American Business Chamber (GABC) of Florida’s highest honor – the German-American Award of Excellence 2012 – at a reception on May 31 at Northern Trust Bank in Miami.
“Dr. Claudia Hillinger is a shining example of an executive in the German American community who is making a significant impact not only in South Florida, but around the

Despite a long-held scientific belief that much of the wiring of the brain is fixed by the time of adolescence, a new study shows that changes in sensory experience can cause massive rewiring of the brain, even as one ages. In addition, the

Samuel M. Young, Jr., PhD, research group leader at the new Max Planck Florida Institute (MPFI), has received his first grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).  The grant will enable Dr. Young and colleagues to develop a technology that will help scientists working in drug development to research potential treatments that target LRRK2, a Parkinson’s-related gene. Globally, five million people have Parkinson’s disease.

“We are excited about receiving The Michael J. Fox Foundation grant, as these grants are competitive and MJFF is the world’s largest private funder of Parkinson’s research,” said Dr. Young,

Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics, today announced its participation in